Jensen Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.6M Buy
105,709
+102,139
+2,861% +$57.3M 1.35% 26
2026
Q1
$2.01M Sell
3,570
-1
-0% -$641 0.04% 65
2025
Q4
$2.42M Sell
3,571
-859
-19% -$585K 0.04% 67
2025
Q3
$2.83M Sell
4,430
-5,980
-57% -$3.63M 0.04% 68
2025
Q2
$5.58M Buy
10,410
+2,220
+27% +$1.06M 0.07% 49
2025
Q1
$3.44M Sell
8,190
-830
-9% -$360K 0.04% 62
2024
Q4
$3.73M Buy
9,020
+930
+11% +$408K 0.03% 64
2024
Q3
$4.09M Buy
8,090
+2,970
+58% +$1.44M 0.03% 67
2024
Q2
$2.49M Buy
+5,120
New +$2.57M 0.02% 80

Other funds holding IDXX

Jensen Investment Management's IDXX Position: Q2 2026 in Review

Jensen Investment Management increased its Idexx Laboratories (IDXX) stake by 2,861% in Q2 2026, buying an estimated $57.3M and bringing the position to 105,709 shares worth $55.6M. The position accounts for 1.35% of the portfolio, ranked #26.

Jensen Investment Management first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. 760 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Jensen Investment Management held 105,709 shares of Idexx Laboratories worth $55.6M as of Q2 2026.
  • Jensen Investment Management bought 102,139 Idexx Laboratories shares in Q2 2026, an estimated $57.3M.
  • Idexx Laboratories made up 1.35% of Jensen Investment Management's portfolio in Q2 2026, its #26 holding.
  • Jensen Investment Management first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
  • 760 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Jensen Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.